Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)

NCT05457699 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

RADIATION: Metastasis directed radiotherapy (MDRT)
OTHER: no MDRT

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)